These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 729609)

  • 1. Preliminary studies of the kinetics of citalopram in man.
    Overø KF
    Eur J Clin Pharmacol; 1978 Nov; 14(1):69-73. PubMed ID: 729609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of citalopram: single and multiple dose studies in man.
    Kragh-Sørensen P; Overø KF; Petersen OL; Jensen K; Parnas W
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):53-60. PubMed ID: 6939299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of citalopram in elderly patients.
    Fredericson Overø K; Toft B; Christophersen L; Gylding-Sabroe JP
    Psychopharmacology (Berl); 1985; 86(3):253-7. PubMed ID: 3929295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.
    Bjerkenstedt L; Flyckt L; Overø KF; Lingjaerde O
    Eur J Clin Pharmacol; 1985; 28(5):553-7. PubMed ID: 3899675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of citalopram in man; plasma levels in patients.
    Fredricson Overø K
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):311-8. PubMed ID: 6959195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of citalopram in the blood serum and in the central nervous system of rats after single and multiple dosage.
    Melzacka M; Rurak A; Adamus A; Daniel W
    Pol J Pharmacol Pharm; 1984; 36(6):675-82. PubMed ID: 6598490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).
    Gottlieb P; Wandall T; Overø KF
    Acta Psychiatr Scand; 1980 Sep; 62(3):236-44. PubMed ID: 6935914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant.
    Gastpar M; Gastpar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):319-25. PubMed ID: 6959196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.
    Pedersen OL; Kragh-Sørensen P; Bjerre M; Overø KF; Gram LF
    Psychopharmacology (Berl); 1982; 77(3):199-204. PubMed ID: 6812140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity of citalopram in rats and first-pass metabolism.
    Fredricson Overø K; Svendsen O
    Arch Toxicol Suppl; 1978; (1):177-80. PubMed ID: 277099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of citalopram in test animals; drug exposure in safety studies.
    Fredricson Overø K
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):297-309. PubMed ID: 6959194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.
    Hyttel J; Overø KF; Arnt J
    Psychopharmacology (Berl); 1984; 83(1):20-7. PubMed ID: 6429698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a specific 5HT uptake inhibitor (citalopram) on drug accumulation by rat lung slices.
    Drew R; Siddik ZH
    Pharmacology; 1980; 20(1):27-31. PubMed ID: 6929555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of three structurally related bicyclic antidepressant compounds--a comparison in the dog.
    Overo KF
    J Pharm Pharmacol; 1973 Dec; 25(12):957-63. PubMed ID: 4150299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibility of modulating morphine analgesia against a background of activation of serotonin- and GABA-ergic processes].
    Andreev BV; Vasil'ev IuN; Ignatov IuD
    Farmakol Toksikol; 1981; 44(1):34-7. PubMed ID: 6973490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone kinetics after oral doses.
    Kannan R; Nademanee K; Hendrickson JA; Rostami HJ; Singh BN
    Clin Pharmacol Ther; 1982 Apr; 31(4):438-44. PubMed ID: 7060325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric identification of amiodarone N-monodesethyl metabolite and application of an HPLC method to a pharmacokinetic study.
    Marchiset D; Aubert C; Sumirtapura YC; Egre A; Cano JP
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):123-8. PubMed ID: 6745303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram: a new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties.
    Pawłowski L; Ruczyńska J; Górka Z
    Psychopharmacology (Berl); 1981; 74(2):161-5. PubMed ID: 6267647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.
    Hicks DC; Phillips EM
    Br J Pharmacol; 1972 Feb; 44(2):377P-378P. PubMed ID: 4148922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.